PolyNovo Limited (ASX:PNV)

Australia · Delayed Price · Currency is AUD

0.9950

+0.0250 (2.58%)

At close: Feb 5, 2026

Revenue by Product

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Commercial Product	92.04M
Commercial Product Growth	54.49%
Biomedical Advanced Research and Development Authority	11.15M
Biomedical Advanced Research and Development Authority Growth	96.89%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
United States	79.84M
United States Growth	54.23%
Other Countries	16.80M
Other Countries Growth	92.87%
Australia and New Zealand	6.56M
Australia and New Zealand Growth	37.55%